Andrew Dahl, founder and chairman of BioMEMS Diagnostics, shared how his business seeks to transform the diagnostics sector, in response to emailed questions. Why did you start this company?

Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "BioChips & BioMEMS - Global Markets by Products, End-Users, Applications and Competition" report from Dedalus Consulting has been added to ...

BioMEMS Diagnostics, a Michigan-based diagnostics developer, has opened an assay development/optimization laboratory on the Gunnison, Colorado campus of Western ...

A detailed report analyzing current trends in the dynamic and growing market for BioChips and BioMEMS including DNA chips, lab-on-a-chip, biosensors, drug delivery systems, microfluidic devices, ...

Nanotechnology, VLSI fabrication, genetic engineering and drug design intersect in the rapidly developing field of BioMEMS, a curious blend of organic and inorganic systems that is seeing explosive ...

The BioMEMS 768 Sequencer can sequence the entire human genome in only one year, processing up to 7 million DNA letters a day, about seven times faster than its nearest rival. Scientists began working ...

Now an ambitious EU-funded project, SMART-BIOMEMS, is in the process of fabricating a novel microsystem – a lab on a microfluidic chip – which can be used in a portable diagnostic device, to ...

The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The ...

PORTLAND, Ore. — Widely considered the father of bioMEMS, Professor Mauro Ferrari has founded a company to commercialize MEMS-based medical solutions and possible space applications. NanoMedical ...

The course deals with the foundational aspects of Bio-MEMS, viz., their design/analysis, microfabrication and biological relevance.